- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05701917
TRANS: RCT av ClotTriever-systemet versus antikoagulasjon ved dyp venetrombose (DEFIANCE)
DEFIANCE - ClotTriever® trombektomisystem vs. antikoagulasjon alene for behandling av dyp venetrombose
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.
Studieoversikt
Status
Detaljert beskrivelse
The study will compare the clinical outcomes of patients treated with an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of symptomatic unilateral iliofemoral DVT. Approximately 300 subjects will be enrolled and randomized. All subjects who sign informed consent and who meet all of the inclusion criteria and none of the exclusion criteria will be randomized (1:1, ClotTriever Intervention Arm or Conservative Medical Management Arm).
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Sara Willis
- E-post: sara.willis@stryker.com
Studer Kontakt Backup
- Navn: Mark Sung
- Telefonnummer: 949-466-9458
- E-post: mark.sung@stryker.com
Studiesteder
-
-
-
Helsinki, Finland
- Rekruttering
- Helsinki University Hospital
-
Ta kontakt med:
- Matti Laine, MD, PhD
-
-
-
-
Arizona
-
Scottsdale, Arizona, Forente stater, 85258
- Rekruttering
- Honor Health
-
Ta kontakt med:
- Venkataramanan Gangadharan, MD
-
Tucson, Arizona, Forente stater, 85704
- Rekruttering
- Pima Heart and Vascular
-
Ta kontakt med:
- Joseph Sabat, MD
-
-
California
-
Orange, California, Forente stater, 92868
- Rekruttering
- UCI Medical Center
-
Ta kontakt med:
- Anthony H Chau, MD
-
Orange, California, Forente stater, 92868
- Rekruttering
- Vascular and Interventional Specialists of Orange County
-
Ta kontakt med:
- Theodore Bryan, MD
-
Pasadena, California, Forente stater, 91105
- Rekruttering
- Huntington Health
-
Ta kontakt med:
- Theodore Teruya, MD
-
-
Colorado
-
Denver, Colorado, Forente stater, 80045
- Rekruttering
- University Of Colorado
-
Ta kontakt med:
- Jonathan D Lindquist, MD
-
-
Connecticut
-
New Haven, Connecticut, Forente stater, 06520
- Rekruttering
- Yale University
-
Ta kontakt med:
- Hamid R Mojibian, MD
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20010
- Rekruttering
- MedStar Health Research Institution
-
Ta kontakt med:
- Saher S Sabri, MD
-
-
Florida
-
Bradenton, Florida, Forente stater, 34208
- Avsluttet
- Manatee Memorial Hospital
-
Jacksonville, Florida, Forente stater, 32207
- Rekruttering
- Baptist Health Research Institute
-
Ta kontakt med:
- Bharat Gummadi, MD
-
Lakeland, Florida, Forente stater, 33805
- Avsluttet
- Lakeland Vascular Institute
-
Largo, Florida, Forente stater, 33770
- Avsluttet
- HCA Florida Largo Hospital
-
Sarasota, Florida, Forente stater, 34239
- Rekruttering
- Sarasota Memorial Hospital
-
Ta kontakt med:
- Juan C Camacho-Vasquez, MD
-
Tampa, Florida, Forente stater, 33607
- Rekruttering
- BayCare Health System
-
Ta kontakt med:
- Nicholas Turman, MD
-
-
Georgia
-
Savannah, Georgia, Forente stater, 31404
- Avsluttet
- Memorial Health University Medical Center
-
-
Indiana
-
Munster, Indiana, Forente stater, 46321
- Avsluttet
- Community Healthcare System
-
-
Kentucky
-
Edgewood, Kentucky, Forente stater, 41017
- Avsluttet
- St. Elizabeth Edgewood
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201
- Rekruttering
- University of Maryland
-
Ta kontakt med:
- Khanjan Nagarsheth, MD
-
-
Michigan
-
Bay City, Michigan, Forente stater, 48708
- Rekruttering
- McLaren Healthcare
-
Ta kontakt med:
- Nicolas Mouawad, MD
-
Detroit, Michigan, Forente stater, 48202
- Rekruttering
- Henry Ford Health
-
Ta kontakt med:
- Scott Kaatz, MD
-
Midland, Michigan, Forente stater, 48670
- Rekruttering
- MyMichigan Medical Center
-
Ta kontakt med:
- Contantinos Constantinou, MD
-
-
Missouri
-
Columbia, Missouri, Forente stater, 65212
- Rekruttering
- University of Missouri
-
Ta kontakt med:
- Ambarish Bhat, MD
-
Kansas City, Missouri, Forente stater, 64131
- Avsluttet
- Saint Luke's Hospital of Kansas City
-
St Louis, Missouri, Forente stater, 63104
- Rekruttering
- St. Louis University
-
Ta kontakt med:
- Keith Pereira, MD
-
-
Nevada
-
Las Vegas, Nevada, Forente stater, 89102
- Rekruttering
- University Medical Center of Southern Nevada
-
Ta kontakt med:
- Ryan Rimer, MD
-
-
New Jersey
-
Camden, New Jersey, Forente stater, 08103
- Rekruttering
- Cooper University Hospital
-
Ta kontakt med:
- Laurel Hastings, MD
-
Teaneck, New Jersey, Forente stater, 07666
- Avsluttet
- Holy Name Medical Center
-
-
New York
-
Bay Shore, New York, Forente stater, 11706
- Rekruttering
- Northwell Health
-
Ta kontakt med:
- Jonathan A Schor, MD
-
Brooklyn, New York, Forente stater, 11215
- Rekruttering
- NYP-Brooklyn Methodist
-
Ta kontakt med:
- Rajesh K Malik, MD
-
Buffalo, New York, Forente stater, 14203
- Avsluttet
- SUNY, The University at Buffalo
-
New York, New York, Forente stater, 10032
- Rekruttering
- Columbia University Irving Medical Center
-
Ta kontakt med:
- Edvard Skripochnik, MD
-
New York, New York, Forente stater, 10016
- Rekruttering
- NYU Langone Medical Center
-
Ta kontakt med:
- Katherine Teter, MD
-
-
North Carolina
-
Asheville, North Carolina, Forente stater, 28801
- Avsluttet
- Mission Health
-
-
Ohio
-
Cincinnati, Ohio, Forente stater, 45211
- Avsluttet
- Mercy Health - The Heart Institute
-
Cleveland, Ohio, Forente stater, 44195
- Rekruttering
- Cleveland Clinic
-
Ta kontakt med:
- Aravinda Nanjundappa, MD
-
-
Oklahoma
-
Tulsa, Oklahoma, Forente stater, 74136
- Rekruttering
- Saint Francis Hospital
-
Ta kontakt med:
- Tucker J Harrison, DO
-
-
Pennsylvania
-
Erie, Pennsylvania, Forente stater, 16544
- Rekruttering
- Allegheny St. Vincent Hospital
-
Ta kontakt med:
- Orestis Pappas, MD
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Rekruttering
- Thomas Jefferson University
-
Ta kontakt med:
- Robert W Ford, MD
-
Pittsburgh, Pennsylvania, Forente stater, 15212
- Rekruttering
- Allegheny General Health Research Network
-
Ta kontakt med:
- Abdullah A Shaikh, MD
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02903
- Rekruttering
- Rhode Island Hospital
-
Ta kontakt med:
- John Lee, MD
-
-
South Carolina
-
Greenville, South Carolina, Forente stater, 29615
- Avsluttet
- Prisma Health Upstate
-
Spartanburg, South Carolina, Forente stater, 29303
- Rekruttering
- Spartanburg Medical Center
-
Ta kontakt med:
- Brian J Brown, MD
-
West Columbia, South Carolina, Forente stater, 29169
- Avsluttet
- Lexington Medical Center
-
-
Tennessee
-
Nashville, Tennessee, Forente stater, 37232
- Rekruttering
- Vanderbilt University Medical Center
-
Ta kontakt med:
- Mark D Iafrati, MD
-
-
Texas
-
Dallas, Texas, Forente stater, 75390
- Rekruttering
- Clements University Hospital (UTSW)
-
Ta kontakt med:
- Michael C Siah, MD
-
-
Virginia
-
Norfolk, Virginia, Forente stater, 23507
- Rekruttering
- Sentara Norfolk General Hospital
-
Ta kontakt med:
- David J Dexter, MD
-
-
Washington
-
Spokane, Washington, Forente stater, 99204
- Avsluttet
- Providence Sacred Heart Med Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forente stater, 53215
- Avsluttet
- Aurora St. Luke's Medical Center
-
-
-
-
-
London, Storbritannia
- Rekruttering
- Imperial College
-
Ta kontakt med:
- Alun H Davies, Prof.
-
London, Storbritannia
- Rekruttering
- GSST London/St Thomas
-
Ta kontakt med:
- Taha Khan, Mr
-
Newcastle upon Tyne, Storbritannia
- Rekruttering
- Freeman Hospital Newcastle upon Tyne
-
Ta kontakt med:
- Sandip Nandhra, Dr.
-
Oxford, Storbritannia
- Rekruttering
- Oxford - John Radcliffe
-
Ta kontakt med:
- Andrew Wigham, Dr
-
-
-
-
-
Baden, Sveits
- Rekruttering
- Kantonsspital Baden
-
Ta kontakt med:
- Michael Kostrzewa, Dr.
-
Bern, Sveits
- Rekruttering
- Inselspital, Universitätsspital Bern
-
Ta kontakt med:
- Marc Schindewolf, Dr. med.
-
Lucerne, Sveits
- Rekruttering
- Luzerner Kantonsspital
-
Ta kontakt med:
- Thorsten Grumann, Dr. med.
-
-
-
-
-
Augsburg, Tyskland
- Rekruttering
- Universitätsklinikum Augsburg
-
Ta kontakt med:
- Christian Scheurig-Münkler, PD Dr.
-
Heidelberg, Tyskland
- Rekruttering
- Universitätsklinikum Heidelberg
-
Ta kontakt med:
- Christian Erbel, Prof. Dr.
-
-
Baden-Würtemberg
-
Tübingen, Baden-Würtemberg, Tyskland, 72076
- Rekruttering
- Universitätsklinikum Tübingen
-
Ta kontakt med:
- Gerd Grözinger, Dr. med.
-
-
Hesse
-
Frankfurt am Main, Hesse, Tyskland, 60389
- Rekruttering
- MVZ CCB Frankfurt und Main-Taunus GbR
-
Ta kontakt med:
- Michael Piorkowski, Dr. med.
-
-
North Rhine-Westphalia
-
Arnsberg, North Rhine-Westphalia, Tyskland, 59759
- Rekruttering
- Klinikum Hochsauerland GmbH
-
Ta kontakt med:
- Michael Lichtenberg, MD
-
-
Saxony
-
Leipzig, Saxony, Tyskland, 04109
- Rekruttering
- Universität Leipzig
-
Ta kontakt med:
- Andrej Schmidt, Prof Dr med
-
-
State of Berlin
-
Berlin, State of Berlin, Tyskland, 10117
- Avsluttet
- Charité - Universitätsmedizin Berlin
-
-
-
-
-
Vienna, Østerrike
- Rekruttering
- Vienna General Hospital (AKH Wien)
-
Ta kontakt med:
- Oliver Schlager, Dr. med
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria
- Age ≥ 18 years
- Proximal lower extremity unilateral DVT involving at least the common femoral, external iliac, or common iliac veins, alone or in combination
- Symptom onset within 12 weeks of enrollment in the study
- Significant symptoms, as defined by a Villalta score > 9
- Willing and able to provide informed consent
Exclusion Criteria
- Bilateral iliofemoral DVT
- Prior venous stent in the target venous segment
- IVC aplasia/hypoplasia or other congenital anatomic anomalies of the IVC or iliac veins
- IVC filter in place at the time of enrollment
- Limb-threatening circulatory compromise (e.g., phlegmasia)
- Clot in transit including IVC thrombus presenting as extension of >2cm into the IVC from the CIV
- Symptomatic PE with right heart strain where the physician judges that a DVT intervention is inappropriate at this time.
- Inability to be a candidate for intervention due to medical or technical reasons based on physician judgement
- Severe allergy, hypersensitivity to, or thrombocytopenia from heparin
- Severe allergy to iodinated contrast agents that cannot be mitigated
- Hemoglobin < 8.0 g/dL, INR > 1.7 before warfarin was started, or platelets < 50,000/µl which cannot be corrected prior to enrollment
- Severe renal impairment (estimated GFR < 30 ml/min) in patients who are not yet on dialysis
- Inability to provide therapeutic anticoagulation per Investigator discretion
- Uncontrolled severe hypertension on repeated readings (systolic > 180mmHg or diastolic > 105mmHg)
- Recently (< 30 days) had DVT interventional procedure
- Subject is participating in another study that may interfere with this study
- Life expectancy < 6 months or chronic non-ambulatory status
- Known hypercoagulable states that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject (e.g., contraindication to use of ClotTriever per local approved labeling, compromise the well-being or that could prevent, limit, or confound the protocol-specified assessments)
- Subject has previously completed or withdrawn from this study
- Patient unwilling or unable to conduct the follow up visits per protocol
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Interventional
Interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm). |
Mechanical thrombectomy |
|
Aktiv komparator: Conservative Medical Management
Conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm). |
Anticoagulants are a group of medications that decrease your blood's ability to clot. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Composite clinical endpoint constructed as a win ratio, a hierarchy of the following:
Tidsramme: 180 Days (+-14 Days)
|
|
180 Days (+-14 Days)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Composite clinical endpoint constructed as a win ratio, a hierarchy of the following:
Tidsramme: 10 Days (+- 3 Days)
|
|
10 Days (+- 3 Days)
|
|
Assessment of PTS Severity:
Tidsramme: 180 Days (+-14 Days)
|
a. Assessment of PTS severity, as defined by the Villalta scale |
180 Days (+-14 Days)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Steven Abramowitz, MD, MedStar Health Research Institution
- Hovedetterforsker: Stephen Black, MD, St Thomas' Hospital (UK)
- Hovedetterforsker: Xhorlina Marko, MD, Henry Ford Health
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Abramowitz SD, Marko X, D'Souza D, Noor S, Pereira K, Silver MJ, Rosenberg SP, Markovitz CD, Tu T, Weinberg I, Black S. Rationale and design of the DEFIANCE study: A randomized controlled trial of mechanical thrombectomy versus anticoagulation alone for iliofemoral deep vein thrombosis. Am Heart J. 2025 Mar;281:92-102. doi: 10.1016/j.ahj.2024.10.016. Epub 2024 Nov 3.
- Flumignan RL, Nakano LC, Flumignan CD, Baptista-Silva JC. Angioplasty or stenting for deep venous thrombosis. Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011468. doi: 10.1002/14651858.CD011468.pub2.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Vaskulære sykdommer
- Kardiovaskulære sykdommer
- Embolisme og trombose
- Venøs insuffisiens
- Tromboemboli
- Trombose
- Venøs trombose
- Posttrombotisk syndrom
- Venøs tromboembolisme
- Svovelforbindelser
- Organiske kjemikalier
- Heterocykliske forbindelser, 1-ring
- Heterocykliske forbindelser
- Heterocykliske forbindelser, 2-ring
- Heterocykliske forbindelser, smeltet ringen
- Pyraner
- Morfoliner
- Oksaziner
- Tiophener
- Kumariner
- Benzopyraner
- 4-hydroxycoumarins
- Rivaroksaban
- Warfarin
- Apixaban
Andre studie-ID-numre
- 22-001
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .